Poor Jobs Report Bo...
Health Care: Drugs
Exact Sciences Corporation (EXAS: NASDAQ)
$9.55 -0.10 | -1.04%
06/04/12 - 12:25 PM ET
TheStreet Ratings Grade for EXAS
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Stong Buy | 11 | 11 | 11 | 11 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 |
| Mean Rec. | 1.57 | 1.57 | 1.57 | 1.57 |
Portfolios with EXAS
- Portfolio NameUser Type
- Contributor22 Biopharma Stocks With Br...
- Contributor8 Health Care Stocks With R...
- Usergdean1
- Userradforj John's SEP & Ta...
- UserBlind Rookie
- Userbbrads Portfolio 1
- Userremodelit Portfolio 1
- UserGoBears Under $5 Stock Picks
- UserMornan
- Userjwpao Portfolio 1
Latest EXAS Headlines from TheStreet
- 22 Biopharma Stocks With Breakout Potential in 2012 05.22.12 | 08:05 am
- Look to Exact Sciences, Not Radient Pharma, for Best Colon Cancer Screen Test 01.23.12 | 01:01 pm
- Biotech Stock Mailbag: YM Bio, Exact, Peregrine 12.09.11 | 06:12 am
- Exact Sciences Corporation (EXAS): CORRECTION 10.06.11 | 04:10 pm
- Exact Sciences' Colon Cancer Screening Trial 07.12.11 | 08:07 am
- 8 Health Care Stocks With Recent Gains 06.29.11 | 02:06 pm
- Biotech Stock Mailbag: Neoprobe 05.06.11 | 07:05 am
- Radient Pharma Readies Onko-Sure Data 03.29.11 | 02:03 pm
- Mayo Clinic Denies Test Link to Radient Pharma 03.07.11 | 05:03 pm
- Biotech Stock Mailbag: Exact Sciences 02.25.11 | 07:02 am
Press Releases for EXAS
- Exact Sciences To Participate In June Investor Conferences - Business Wire 05.30.12 | 10:05 am
- Exact Sciences Extends, Expands Relationship With Mayo Clinic - Business Wire 05.17.12 | 09:05 am
- Exact Sciences To Participate In May Investor Conferences - Business Wire 05.07.12 | 11:05 am
- Exact Sciences Reports First-Quarter 2012 Financial Results - Business Wire 05.01.12 | 07:05 am
- Exact Sciences To Host First-Quarter 2012 Results Webcast And Call - Business Wire 04.23.12 | 02:04 pm
- Exact Sciences’ Executives, Colon Cancer Challenge Leaders To Ring Nasdaq Opening Bell - Business Wire 03.19.12 | 09:03 am
- Exact Sciences To Participate In March Investor Conferences - Business Wire 02.29.12 | 11:02 am
- Exact Sciences Reports Fourth-Quarter, Full-Year 2011 Financial Results - Business Wire 02.23.12 | 07:02 am
- Exact Sciences Announces Appointment Of Stoltenberg As Chief Commercial Officer - Business Wire 02.20.12 | 04:02 pm
- Exact Sciences Promotes Arora To Chief Operating Officer - Business Wire 02.16.12 | 04:02 pm
Partner Headlines for EXAS
- UPDATE: Auriga Raises PT to $13 on EXACT Sciences - Benzinga 02.24.12 | 04:02 pm
- Exact Sciences Promotes Arora to Chief Operating Officer - Benzinga 02.16.12 | 04:02 pm
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- Momentum Ideas: Friday's High Volume Gainers Chased by Big Money Managers - Seeking Alpha 04.17.11 | 07:04 am
- Cramer's Mad Money - 6 Earnings and IPOs to Watch for the Coming Week (4/8/11) - Seeking Alpha 04.10.11 | 04:04 am
- Life Science Portfolios: Reflecting on a Year of Out-Performance - Seeking Alpha 12.29.10 | 05:12 am
- UPDATE1-New colon cancer test works without colonoscopy - Reuters 10.28.10 | 05:10 pm
- Detecting More Upside Potential for EXACT Sciences - Seeking Alpha 10.22.10 | 09:10 pm
- Piper Jaffray’s Top Picks for The Second Half of 2010 (CPHD, EXAS, GNMK) - Benzinga 08.24.10 | 09:08 am
- 6 Ways to Trade FDA and Clinical Trial News - Seeking Alpha 05.28.10 | 02:05 pm
